Combination therapy of infiximab and granulocyte/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis

Acta Dermato-Venereologica

Volumn 93, Issue 3, 2013, Pages 364-365

  Fujisawa, Tomomi ^a   Moriya, Chie ^a   Shibuya, Yoshinao ^a   Kanoh, Hiroyuki ^a   Seishima, Mariko ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; CYCLOSPORIN; ETRETINATE; INFLIXIMAB; LOXOPROFEN; METHOTREXATE; PREDNISOLONE; STEROID; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADD ON THERAPY; ADULT; APHERESIS; ARTHRALGIA; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; GRANULOCYTE MONOCYTE ADSORPTION THERAPY; HUMAN; LETTER; LEUKOCYTE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; RASH; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE; ADSORPTION; ARTHRITIS, PSORIATIC; DRUG EFFECTS; GRANULOCYTE; IMMUNOLOGY; LEUKAPHERESIS; MIDDLE AGED; MONOCYTE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; PSORIASIS; SKIN; TREATMENT OUTCOME; DRUG EFFECT; METHODOLOGY;

ADSORPTION; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; COMBINED MODALITY THERAPY; FEMALE; GRANULOCYTES; HUMANS; LEUKAPHERESIS; MIDDLE AGED; MONOCYTES; PSORIASIS; REMISSION INDUCTION; SKIN; TREATMENT OUTCOME;

EID: 84876964060     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1463     Document Type: Letter

References (10)

1. Lisby S, Gniadecki R. Infiximab (Remicade) for acute, severe pustular and erythrodermic psoriasis. Acta Derm Venereol 2004; 84: 247-248.
2. Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, et al. Infiximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 2005; 366: 1367-1374.
3. Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler DA, et al. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009; 161: 987-1019.
4. Kanekura T, Yoshii N, Yonezawa T, Kawabata H, Saru-watari H, Kanzaki T. Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2003; 49: 329-332.
5. Fujisawa T, Murase K, Okumura Y, Kanoh H, Doi T, Yoshida S, et al. Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption aphere-sis. Ther Apher Dial 2011; 15: 374-378.
6. Hiraishi K, Takeda Y, Shiobara N, Shibusawa H, Jimma F, Kashiwagi N, et al. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based gra-nulocyte and monocyte adsorptive apheresis. Ther Apher Dial 2003; 7: 334-340.
7. Sanchez-Garcia J, Serrano-López J, García-Sanchez V, Alvarez-Rivas MA, Jimenez-Moreno R, Perez-Seoane C, et al. Tumor necrosis factor-α-secreting CD16+ antigen presenting cells are effectively removed by granulocytaphe-resis in ulcerative colitis patients. J Gastroenterol Hepatol 2010; 25: 1869-1875.
8. Fujisawa T, Murase K, Kanoh H, Takemura M, Ohnishi H, Seishima M. Adsorptive depletion of CD14+/CD16+ proinfammatory monocyte phenotype in patients with generalized pustular psoriasis: clinical efficacy and effects on cytokines. Ther Apher Dial 2012; 16: 436-444.
9. Fukunaga K, Yokoyama Y, Kamikozuru K, Yoshida K, Kikuyama R, Nagase K, et al. Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infiximab in Crohn's disease. J Clin Apher 2010; 25: 226-228.
10. Kato S, Kani K, Takabayashi H, Yamamoto R, Ogawa T, Matsuda A, et al. Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: A report on two drug refractory cases. Intern Med 2011; 50: 1591-1593.